(-)-epigallocatechin 3-gallate multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZNF367 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP367 mRNA CTD PMID:36331819 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ZFP367 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ZFP367 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP367 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO ZNF367 (Homo sapiens) 6480464 Estradiol results in increased expression of ZNF367 mRNA CTD PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ZFP367 mRNA CTD PMID:21570461 and PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Zfp367 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ZFP367 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO ZNF367 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of ZNF367 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP367 mRNA CTD PMID:17942748 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of ZFP367 mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression ISO Zfp367 (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 4,4'-diaminodiphenylmethane increases expression ISO Zfp367 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of ZFP367 mRNA CTD PMID:30723492 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of ZFP367 mRNA CTD PMID:19191707 5-fluorouracil decreases expression ISO ZNF367 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of ZNF367 mRNA CTD PMID:16510598 6-propyl-2-thiouracil increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of ZFP367 mRNA CTD PMID:30047161 acetamide increases expression ISO Zfp367 (Rattus norvegicus) 6480464 acetamide results in increased expression of ZFP367 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of ZFP367 mRNA CTD PMID:23630614 and PMID:25378103 aflatoxin M1 decreases expression ISO ZNF367 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of ZNF367 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO ZNF367 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ZNF367 mRNA CTD PMID:33167477 amitrole increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Amitrole results in increased expression of ZFP367 mRNA CTD PMID:30047161 aristolochic acid A decreases expression ISO ZNF367 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ZNF367 mRNA CTD PMID:33212167 bazedoxifene decreases expression ISO ZNF367 (Homo sapiens) 6480464 bazedoxifene results in decreased expression of ZNF367 mRNA CTD PMID:19914376 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of ZFP367 mRNA CTD PMID:22228805 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP367 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ZFP367 mRNA CTD PMID:21964900 benzo[a]pyrene diol epoxide I decreases expression ISO ZNF367 (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of ZFP367 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP367 mRNA CTD PMID:27858113 bisphenol A increases expression ISO Zfp367 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ZNF367 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Zfp367 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of ZFP367 mRNA CTD PMID:34947998 bisphenol A affects expression ISO Zfp367 (Rattus norvegicus) 6480464 bisphenol A affects the expression of ZFP367 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO ZNF367 (Homo sapiens) 6480464 bisphenol A analog results in decreased expression of ZNF367 mRNA and bisphenol A results in decreased expression of ZNF367 mRNA CTD PMID:29275510 and PMID:32387340 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of ZFP367 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ZFP367 mRNA CTD PMID:25594700 butanal decreases expression ISO ZNF367 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of ZNF367 mRNA CTD PMID:26079696 calcitriol multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ZNF367 mRNA CTD PMID:21592394 calcitriol decreases expression ISO ZNF367 (Homo sapiens) 6480464 Calcitriol results in decreased expression of ZNF367 mRNA CTD PMID:21592394 cannabidiol decreases expression ISO ZNF367 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of ZNF367 mRNA CTD PMID:33244087 cefaloridine increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Cephaloridine results in increased expression of ZFP367 mRNA CTD PMID:18500788 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP367 gene and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of ZFP367 CTD PMID:20938992 chrysene decreases expression EXP 6480464 chrysene results in decreased expression of ZFP367 mRNA CTD PMID:26377693 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP367 mRNA CTD PMID:27858113 cisplatin increases expression ISO ZNF367 (Homo sapiens) 6480464 Cisplatin results in increased expression of ZNF367 mRNA CTD PMID:27594783 cobalt dichloride increases expression ISO Zfp367 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of ZFP367 mRNA CTD PMID:24386269 coumestrol multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO ZNF367 (Homo sapiens) 6480464 Coumestrol results in increased expression of ZNF367 mRNA CTD PMID:19167446 cyclosporin A decreases expression ISO ZNF367 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of ZNF367 mRNA CTD PMID:19159671 and PMID:25562108 deguelin decreases expression ISO ZNF367 (Homo sapiens) 6480464 deguelin results in decreased expression of ZNF367 mRNA CTD PMID:33512557 diazinon increases methylation ISO ZNF367 (Homo sapiens) 6480464 Diazinon results in increased methylation of ZNF367 gene CTD PMID:22964155 diethyl maleate increases expression ISO Zfp367 (Rattus norvegicus) 6480464 diethyl maleate results in increased expression of ZNF367 mRNA CTD PMID:21161181 dioxygen decreases expression ISO ZNF367 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of ZNF367 mRNA CTD PMID:26516004 Enterolactone multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF367 mRNA CTD PMID:19167446 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of ZFP367 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO ZNF367 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of ZNF367 mRNA CTD PMID:23649840 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of ZFP367 mRNA CTD PMID:25629700 formaldehyde increases expression ISO ZNF367 (Homo sapiens) 6480464 Formaldehyde results in increased expression of ZNF367 mRNA CTD PMID:23649840 furan decreases methylation ISO Zfp367 (Rattus norvegicus) 6480464 furan results in decreased methylation of ZFP367 gene CTD PMID:22079235 furan increases expression ISO Zfp367 (Rattus norvegicus) 6480464 furan results in increased expression of ZFP367 mRNA CTD PMID:25539665 gentamycin increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ZFP367 mRNA CTD PMID:33387578 glutathione increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Glutathione deficiency results in increased expression of ZFP367 mRNA CTD PMID:20621112 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP367 gene and [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of ZFP367 CTD PMID:20938992 leflunomide decreases expression ISO ZNF367 (Homo sapiens) 6480464 leflunomide results in decreased expression of ZNF367 mRNA CTD PMID:28988120 methimazole increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Methimazole results in increased expression of ZFP367 mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO ZNF367 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ZNF367 mRNA CTD PMID:23649840 methylparaben decreases expression ISO ZNF367 (Homo sapiens) 6480464 methylparaben results in decreased expression of ZNF367 mRNA CTD PMID:31745603 nickel atom increases expression ISO ZNF367 (Homo sapiens) 6480464 Nickel results in increased expression of ZNF367 mRNA CTD PMID:24768652 and PMID:25583101 niclosamide decreases expression ISO ZNF367 (Homo sapiens) 6480464 Niclosamide results in decreased expression of ZNF367 mRNA CTD PMID:36318118 oxaliplatin multiple interactions ISO Zfp367 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ZFP367 mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO Zfp367 (Rattus norvegicus) 6480464 oxaliplatin results in decreased expression of ZFP367 mRNA CTD PMID:25729387 paracetamol increases expression ISO ZNF367 (Homo sapiens) 6480464 Acetaminophen results in increased expression of ZNF367 mRNA CTD PMID:22230336 paracetamol increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of ZFP367 mRNA CTD PMID:33387578 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 pentanal decreases expression ISO ZNF367 (Homo sapiens) 6480464 pentanal results in decreased expression of ZNF367 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP367 mRNA CTD PMID:36331819 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of ZFP367 mRNA CTD PMID:23091169 PhIP increases expression ISO Zfp367 (Rattus norvegicus) 6480464 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of ZFP367 mRNA CTD PMID:29877212 potassium chromate multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZNF367 mRNA CTD PMID:22079256 potassium chromate increases expression ISO ZNF367 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of ZNF367 mRNA CTD PMID:22079256 progesterone decreases expression ISO ZNF367 (Homo sapiens) 6480464 Progesterone results in decreased expression of ZNF367 mRNA CTD PMID:21795739 resveratrol multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of ZNF367 mRNA CTD PMID:19167446 resveratrol increases expression ISO ZNF367 (Homo sapiens) 6480464 resveratrol results in increased expression of ZNF367 mRNA CTD PMID:19167446 rotenone decreases expression ISO ZNF367 (Homo sapiens) 6480464 Rotenone results in decreased expression of ZNF367 mRNA CTD PMID:33512557 senecionine increases expression ISO Zfp367 (Rattus norvegicus) 6480464 senecionine results in increased expression of ZFP367 mRNA CTD PMID:32419051 sodium arsenite increases expression ISO ZNF367 (Homo sapiens) 6480464 sodium arsenite results in increased expression of ZNF367 mRNA CTD PMID:34032870 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ZFP367 mRNA CTD PMID:37682722 sodium dichromate affects expression ISO Zfp367 (Rattus norvegicus) 6480464 sodium bichromate affects the expression of ZFP367 mRNA CTD PMID:22110744 sodium dichromate increases expression ISO Zfp367 (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of ZFP367 mRNA CTD PMID:25993096 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP367 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP367 mRNA CTD PMID:21641980 and PMID:26378955 sulfadimethoxine increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of ZFP367 mRNA CTD PMID:30047161 sunitinib decreases expression ISO ZNF367 (Homo sapiens) 6480464 Sunitinib results in decreased expression of ZNF367 mRNA CTD PMID:31533062 tebufenpyrad increases expression ISO ZNF367 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of ZNF367 mRNA CTD PMID:33512557 testosterone multiple interactions ISO ZNF367 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ZNF367 mRNA CTD PMID:21592394 testosterone decreases expression ISO ZNF367 (Homo sapiens) 6480464 Testosterone results in decreased expression of ZNF367 mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ZFP367 mRNA CTD PMID:31919559 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP367 mRNA CTD PMID:27858113 thioacetamide increases expression ISO Zfp367 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of ZFP367 mRNA CTD PMID:34492290 topotecan decreases expression ISO Zfp367 (Rattus norvegicus) 6480464 Topotecan results in decreased expression of ZFP367 mRNA CTD PMID:25729387 topotecan multiple interactions ISO Zfp367 (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ZFP367 mRNA CTD PMID:25729387 tremolite asbestos decreases expression EXP 6480464 tremolite results in decreased expression of ZFP367 mRNA CTD PMID:29279043 trichloroethene increases methylation ISO Zfp367 (Rattus norvegicus) 6480464 Trichloroethylene results in increased methylation of ZFP367 gene CTD PMID:27618143 trichostatin A affects expression ISO ZNF367 (Homo sapiens) 6480464 trichostatin A affects the expression of ZNF367 mRNA CTD PMID:28542535 triphenyl phosphate increases expression ISO Zfp367 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of ZFP367 mRNA CTD PMID:30589522 triptonide increases expression EXP 6480464 triptonide results in increased expression of ZFP367 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ZNF367 mRNA CTD PMID:28973697 tungsten increases expression EXP 6480464 Tungsten results in increased expression of ZFP367 mRNA CTD PMID:30912803 urethane decreases expression ISO ZNF367 (Homo sapiens) 6480464 Urethane results in decreased expression of ZNF367 mRNA CTD PMID:28818685 valproic acid increases expression ISO ZNF367 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ZNF367 mRNA CTD PMID:29154799 valproic acid increases methylation ISO ZNF367 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ZNF367 gene CTD PMID:29154799